ストックスクリーナーアプリを入手
1.39
0.00%
0.00
アフターアワーズ：
1.43
0.04
+2.88%
Pmv Pharmaceuticals Inc (PMVP) 最新ニュース
PMV Pharmaceuticals (PMVP) to Release Earnings on Friday - MarketBeat
PMV Pharmaceuticals (PMVP) price target decreased by 37.50% to 4.84 - MSN
Short Interest in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Increases By 48.3% - MarketBeat
PMV Pharmaceuticals (PMVP) posts narrower than expected Q4 2025 loss, shares rise 1.37 percent in today's trading.Deceleration Risk - Newser
Is PMV Pharmaceuticals (PMVP) stock priced below intrinsic value (Institutional Demand) 2026-04-22Social Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
PMV Pharmaceuticals names Laurie Stelzer as board chair - Investing.com
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed - TipRanks
PMV Pharmaceuticals names Laurie Stelzer as board chair By Investing.com - Investing.com Canada
[ARS] PMV Pharmaceuticals, Inc. SEC Filing - Stock Titan
PMV Pharmaceuticals Announces Board Chair Transition - Weekly Voice
The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform - Weekly Voice
As PMV nears a 2027 drug filing, its board chair changes hands - Stock Titan
Board shifts and pay vote in PMV Pharmaceuticals (NASDAQ: PMVP) 2026 proxy - Stock Titan
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Invest In Growth? - Yahoo Finance
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
PMV Pharmaceuticals (NASDAQ:PMVP) Stock Rating Upgraded by Evercore - MarketBeat
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI - TipRanks
Stock List: Research Stocks from Around the World - GuruFocus
GUTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is PMV Pharmaceuticals (PMVP) Stock Breaking Resistance | Price at $1.29, Down 0.77%Social Trading - Newser
Energy Moves: Will PMV Pharmaceuticals Inc outperform its industry peers2026 Momentum & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Dividend Watch: Is PMV Pharmaceuticals Inc exposed to currency risksQuarterly Earnings Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Quarterly Recap: Is Edgewell Personal Care Company forming bullish engulfing patternsIPO Watch & Growth Focused Entry Reports - baoquankhu1.vn
PLRX PE Ratio & Valuation, Is PLRX Overvalued - Intellectia AI
PMVP Stock Analysis: PMV Pharmaceuticals Inc Biotech Performance At 1.34 Price - Cổng thông tin điện tử tỉnh Lào Cai
Cantargia AB (7V3.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
PMVP SEC FilingsPmv Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Large Growth in Short Interest - MarketBeat
Aug Closing: Is PMV Pharmaceuticals Inc exposed to currency risks2026 Market Sentiment & Target Return Focused Stock Picks - baoquankhu1.vn
ICCC PE Ratio & Valuation, Is ICCC Overvalued - Intellectia AI
Why EXEL stock attracts strong analyst attention - baoquankhu1.vn
Analyst Upgrade: Is PMV Pharmaceuticals Inc benefiting from interest rate changesInflation Watch & Verified Swing Trading Watchlists - baoquankhu1.vn
Complete List of HealthcareBiotechnologyBiotechnology Stocks - GuruFocus
PMV Pharmaceuticals Insider Sellers Vindicated After 11% Drop - simplywall.st
Aug Swings: Is PMV Pharmaceuticals Inc exposed to currency risksDip Buying & Low Volatility Stock Recommendations - baoquankhu1.vn
US Market Wrap: Is PMV Pharmaceuticals Inc a potential multi bagger2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Short Interest Update - MarketBeat
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology - TipRanks
PMV Pharmaceuticals (PMVP) CFO receives 240,000-share stock option grant - Stock Titan
COO at PMV Pharmaceuticals (NASDAQ: PMVP) awarded 319,270 options - Stock Titan
PMV Pharmaceuticals (PMVP) awards 303,310 stock options to Chief Development Officer - Stock Titan
PMV Pharmaceuticals (PMVP) awards CEO 744,960 employee stock options - Stock Titan
PMV Pharmaceuticals (NASDAQ:PMVP) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Trend Recap: Does TriNet Group Inc have pricing powerEarnings Overview Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
PMV Pharmaceuticals, Inc.Common Stock (NQ: PMVP - The Chronicle-Journal
Risk On: Whats the outlook for PMV Pharmaceuticals Incs sectorWeekly Trend Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
PMV Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
PMVP Reports Positive Phase 2 Results, Eyes 2027 NDA Submission - GuruFocus
PMV Pharma (PMVP) Reports Decline in Cash Reserves by Year-End 2 - GuruFocus
PMV Pharmaceuticals Reports Progress in PYNNACLE Trial of Rezatapopt for Ovarian Cancer and Announces Orphan Drug Designation from FDA - Quiver Quantitative
PMV Pharmaceuticals 10-K: Revenue $0, EPS $(1.48) — FY2025 results - TradingView
PMVP: Net loss widened to $77.7M as rezatapopt advanced in trials; cash runway extends to Q2 2027 - TradingView
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights - Yahoo Finance
OrbiMed exits PMV Pharmaceuticals (PMVP) after selling 4.98M shares at $1.62 - Stock Titan
PMVP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
StockWatch: AI Drug Developer Generates $400M IPO - Genetic Engineering and Biotechnology News
PMVP Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PMV Pharmaceuticals Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Health Rounds: Researchers find cellular clues to explain faster pain recovery in men - marketscreener.com
PMV Pharma’s rezatapopt study published in New England Journal - Investing.com Australia
2.45%
大文字化:
|
ボリューム (24 時間):